Deep dermal injection of non-absorbable gel polymer for HIV-related lipoatrophy

NICE interventional procedures guidance [IPG439] Published date:

The National Institute for Health and Clinical Excellence (NICE) issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Deep dermal injection of non absorbable gel polymer for HIV-related facial lipoatrophy.

This document replaces previous guidance on Deep dermal injection of non absorbable gel polymer for HIV-related facial lipoatrophy (interventional procedure guidance IPG 291).

  • Description

    HIV-related lipoatrophy is a loss of fat from the skin, often the face, which can occur as a side effect of antiretroviral drug treatment for HIV. Non-absorbable gel polymers are water-based synthetic substances that are not broken down by the body. The gel polymer is injected under the skin to restore the shape and volume of the areas where fat has been lost.

  • OPCS4.6 Code(s)

    S50.4 Injection of inert substance into subcutaneous tissue NEC

    Z47.- Skin of face

    Includes: Subcutaneous tissue of face  

    The NHS Classifications Service of NHS Connecting for Health is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS.   The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided.  www.connectingforhealth.co.uk/clinicalcoding

  • Get involved